2017 News Articles

All | 2020 | 2019 | 2018 | 2017

Heart Attack, Stroke Risk May Be Elevated Following Cancer Diagnosis

A diagnosis of cancer can come with an increased risk of a heart attack or stroke in the months following the diagnosis, findings from a new study suggest. Within 6 months of a cancer diagnosis, in fact, the risk of having... Read More

POSTED: 08/25/2017

 4.7% of study participants with cancer had a heart attack or stroke within 6 months of diagnosis; 2.2% of participants without cancer had a heart attack or stroke within the same 6-month period.

Tackling Cancer Health Disparities: Small Steps, Big Hopes

Several studies have documented that African American men are far more likely than non-Hispanic white men to die of prostate cancer. Other studies have shown that Hispanic women are more likely to be diagnosed with cervical... Read More

POSTED: 07/24/2017

An image containing the logos of the National Cancer Institute, American Society of Clinical Oncology, American Association for Cancer Research, and American Cancer Society

Biomarker Test Could Reduce Unnecessary Biopsies to Detect Prostate Cancer

Testing for two biomarkers in urine may help some men avoid having to undergo an unnecessary biopsy to detect a suspected prostate cancer, findings from a new study show. Read More

POSTED: 06/09/2017

An image of a urine specimen in a collection tube.  Photo credit: iStockPhoto

As the NCI Cancer Prevention Fellowship Program (CPFP) celebrates its 30th anniversary, the successful cycle continues with the call for applications for the next class of fellows, who would start in 2018. The current... Read More

POSTED: 05/23/2017

A group photo of the CPFP fellows taken in 2016.

The Breast and Gynecologic Cancer Research Group (BGCRG), Division of Cancer Prevention (DCP), National Cancer Institute (NCI), has an opening for an experienced Medical Officer. BGCRG focuses on fostering the development... Read More

POSTED: 04/12/2017

Less-Frequent Zoledronic Acid Treatment Effective at Preventing Bone Metastasis Complications

In a clinical trial involving patients with metastatic cancer, administration of zoledronic acid every 12 weeks was as effective at preventing skeletal-related events caused by bone metastases as administration every 4 weeks... Read More

POSTED: 01/30/2017

For Some Breast Cancer Survivors, Drug May Reduce Treatment-Related Joint Pain

A drug most commonly used to treat depression may also reduce joint pain in some women being treated for early-stage breast cancer, according to the results of a randomized clinical trial. Read More

POSTED: 01/04/2017